Stock Price
17.46
Daily Change
-0.16 -0.91%
Monthly
3.62%
Yearly
66.76%
Q1 Forecast
17.09



Peers Price Chg Day Year Date
Agrana Beteiligungs 11.50 0.20 1.77% 7.98% Mar/16
Austevoll Seafood 104.00 0.80 0.78% 4.73% Mar/16
British American Tobacco 4,572.50 53.50 1.18% 42.89% Mar/16
Beiersdorf 77.51 -0.93 -1.19% -42.01% Mar/16
Danone 72.56 0.64 0.89% 1.06% Mar/16
Givaudan 2,834.00 38.00 1.36% -28.67% Mar/16
Glanbia 17.46 -0.16 -0.91% 66.76% Mar/16
Henkel 69.98 -0.10 -0.14% -7.56% Mar/16
International Flavors Fragrances 69.61 -0.40 -0.57% -12.61% Mar/13
Imperial Brands 3,239.50 38.50 1.20% 16.45% Mar/16

Indexes Price Day Year Date
ISEQ 12345 -49.05 -0.40% 12.29% Mar/16
EU600 598 2.19 0.37% 8.55% Mar/16

Glanbia traded at 17.48 this Monday March 16th, decreasing 0.14 or 0.79 percent since the previous trading session. Looking back, over the last four weeks, Glanbia lost 3.74 percent. Over the last 12 months, its price rose by 66.95 percent. Looking ahead, we forecast Glanbia to be priced at 17.09 by the end of this quarter and at 15.60 in one year, according to Trading Economics global macro models projections and analysts expectations.

Glanbia plc is a global nutrition company. The Company operates through two segments: Glanbia Performance Nutrition and Glanbia Nutritionals. The Company's Glanbia Performance Nutrition segment includes performance nutrition products. Its products are sold through a range of channels, including specialty retail, the Internet and gyms in a range of formats, including powders, bars and ready-to-drink beverages. The Company's Glanbia Nutritionals segment provides nutritional solutions. It manufactures and sells cheese, dairy and non-dairy nutritional ingredients and vitamin and mineral premixes targeting the market focus on health and nutrition.